Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Zevra Therapeutics, Inc.

NASDAQ: ZVRA · Life Sciences · 3 alerts · CIK 1434647

Share price
$9.25Close, Nov 16
Market cap
$550M
Shares outstanding
59.5MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Zevra Therapeutics, Inc. filings on SEC EDGAR ↗

4:24 PM ET Form 4
Insider Selling

Zevra Therapeutics President and CEO Neil F. McFarlane Sells $225K of Stock

Neil F. McFarlane, President and CEO, sold 20,000 shares of Zevra Therapeutics, Inc. at $11.25 a share, worth $225K in total on Oct 12, 2026. Shares held after the trade: 417,225 (-4.6%).

Value
$225K
Shares
20,000
Price
$11.25
Role
President and CEO
Holding change
-4.6%
Trade date
Oct 12, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.